Alternative Medicine and Molecular Mechanisms in Chronic Degenerative Diseases


Knowledge of healing plants worldwide properties it has been extensively studied by their biological activities. The increasing number of plant users for healthcare originated the Research Center in Complementary Alternative Medicine, National Institute of Health (NIH) whose primary function is to be alert with a strictly scientific sense about de use of plants as main source of Complementary Alternative Medicine. It is currently about the synergy known that Is achieved on the hepatoprotective, antioxidant and hypoglycaemic activities with mixtures formed by selected plants and combined. These plants are characterized by their content of hidroxyphenolic compounds as cynarin, rosmarinic acid, flavonoids silybin and among others. Actually this kind of herbal preparations are investigated in patients with cirrhosis, type II diabetes mellitus, breast cancer and arthritis diseases. Patients with Chronic Degenerative Diseases are in state of stress and Its metabolism produces free radicals such as superoxide ºO2, hydroxyl ºOH and peroxynitrite highly reactive with unsaturated fatty acids of cell membranes producing lipid peroxidation. The main product of this process is the peroxyl, that when it’s reduced forms hydroxiperoxyle its decomposition forms MDA and 4-hidroxialquenal. These substances bind to R-SH2 of the aminoacids of the proteins and to the thymine of DNA, altering their biological function. Before the treatments with selected and micropulverized plants to patients, it is necessary and required in animal models demonstrate that plants do not produce toxic effects. Using mixtures of plants micropulverized is good choice because these microparticles behave as micro-releasing their constituents with increased activity and bioavailability to target cells so it will be possible to achieve greater power to control their activity and perhaps cure the disease, and provide patients an effective herbal medicine safe, free of toxic effects and low cost.

Share and Cite:

A. Velazquez, M. Beltrán, A. Panduro and L. Ruiz, "Alternative Medicine and Molecular Mechanisms in Chronic Degenerative Diseases," Chinese Medicine, Vol. 2 No. 3, 2011, pp. 84-92. doi: 10.4236/cm.2011.23015.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] R. J. Gallardo, “Medicina Tradicional Purépecha,” 1st Edition, El Colegio de Michoacán, Instituto Mexicano de Cultura AC, México, 2002.
[2] V. D. Waizel, “Las Plantas Medicinales y las Ciencias, Una Visión Multidisciplinaria,” 1st Edition, Instituto Politécnico Nacional, México, 2006.
[3] A. O. Hutterer, “La Medicina Tradicional Cuestionada: Antecedentes, Perspectivas y Prospectivas en México y Latinoamérica,” 1st Edition, Extra Internacional de México S. A. de C. V., México, 2000.
[4] J. B. Calixto, “Twenty-Five Years of Research on Medicinal Plants in Latin America,” Journal of Ethnophar- macology, Vol. 22, No. 100, 2005, pp. 131-134. doi:10.1016/j.jep.2005.06.004
[5] M. L. M. Beltran, A. M. P. Perez, A. G. Sanchez and L. H. Ruiz, “Male Rat Infertility Induction/Spermatozoa and Epididimal Plasma Abnormalities after Oral Administration of Kalanchoe gastonis Bonnieri Natural Juice,” Phytotherapy Research, Vol. 17, No. 4, 2003, pp. 315-319. doi:10.1002/ptr.1131
[6] S. Mutalik, M. Chetana, B. Sulochana, P. Devi and N. Udupa, “Effect of Dianex, a Herbal Formulation on Experimentally Induced Diabetes Mellitus,” Phytotherapy Research, Vol. 19, No. 5, 2005, pp. 409-415. doi:10.1002/ptr.1570
[7] H. W. Hui, G. Tang and V. L. W. Go, “Hypoglycemic Herbs and Their Action Mechanisms,” Chinese Medicine, Vol. 4, No. 11, 2009, pp. 11-21. doi:10.1186/1749-8546-4-11
[8] I. Shimizu, “Sho-Saiko-To Japanese Herbal Medicine for Protection against Hepatic Fibrosis and Carcinoma,” Gastroenterology and Hepatology, Vol. 15, Supplement 1, 2000, pp. 84-90. doi:10.1046/j.1440-1746.2000.02138.x
[9] M. W. Baraka, “Herbal Compositon for Diabetes and Method of Treatment,” US Patent No. 6042834, 28 March 2000.
[10] P. Chiereglin, “Farmacia Verde/Manual Práctico de Herboristeria,” 1st Edition, Madrid J. & Madrid Cenzano, Espa?a, 2000.
[11] L. K. N. Okinea, “The Antidiabetic Activity of the Herbal Preparation ADD-199 in Mice: A Comparative Study with Two Oral Hypoglycaemic Drugs,” Journal of Ethnopharmacology, Vol. 97, No. 1, 2005, pp. 31-38. doi:10.1016/j.jep.2004.09.048
[12] K. T. Leung, C. M. Lawrence and M. Chiu, “In Vitro Antiviral Chinese Medicinal Herbs against Duck Hepatitis B Virus,” Phytotherapy Research, Vol. 20, No. 10, 2006, pp. 911-914. doi:10.1002/ptr.1969
[13] R. L. Huacuja, V. A. L. López, A. Panduro, P. Mondragón and B. M. L. Miranda, “Fitoterapia de la Hepatitis Airal B Crónica,” Investigación en Salud, Vol. 9, No. 3, 2007, pp. 190-197.
[14] R.-L. Huang, Y.-L. Huang, J.-C. Ou, C.-C. Chen, F.-L. Hsu and C. M. Chang, “Screening of 25 Compounds Isolated from Phyllanthus Species for Antihuman Hepatitis B Virus in Vitro,” Phytotherapy Research, Vol. 17, No. 5, 2003, pp. 449-453. doi:10.1002/ptr.1167
[15] G.-B. Yao, “Treatment of Chronic Hepatitis B in China,” Journal of Gastroenterology and Hepatology, Vol. 15, Supplement 2, 2000, pp. E61-E66. doi:10.1046/j.1440-1746.2000.02106.x
[16] T. Mangena and N. Y. O. Muyima, “Comparative Evaluation of the Antimicrobial Activities of Essential Oil of Artemisa afra, Pteronia incana y Rosmarinus officinalis in Selected Bacteria and Yeast Strains,” Letters in Applied Microbiology, Vol. 28, No. 4, 1999, pp. 291-296. doi:10.1046/j.1365-2672.1999.00525.x
[17] G. Rojas, J. Levaro and V. Tortoriello Navarro, “Antimicrobial Evaluation of Certain Plants Used in Mexican Traditional Medicine for the Treatment of Respiratory Diseases,” Journal of Ethnopharmacology, Vol. 74, No. 1, 2001, pp. 97-101. doi:10.1016/S0378-8741(00)00349-4
[18] A. T. Borchers, S. Sakay, G. L. Henderson, M. R. Harkey, C. L. Keen, J. S. Stern, K. Terasawa and M. E. Gershwin, “Shosaiko-To and Other Kampo (Japanese Herbal) Medicines: A Review of Their Inmunomodulatory Activities,” Journal of Ethnopharmacology, Vol. 73, No. 1-2, 2000, pp.1-13. doi:10.1016/S0378-8741(00)00334-2
[19] M. K. Canales and B. M. Geller, “Surviving Breast Cancer. The Role of Complementary Therapies,” Community Health, Vol. 26, No. 1, 2003, pp. 11-24.
[20] S. Gozum, A. Tezel and M. Koc, “Complementary Alternative Treatments Used by Patients with Cancer in Eastern Turkey,” Cancer Nursing, Vol. 26, No. 3, 2003, pp. 230-236. doi:10.1097/00002820-200306000-00010
[21] L. Huacuja, A. M. Puebla, A. Carranco, M. L. Miranda, H. Merchant, A. Reyes and A. Guzman, “Contraceptive Effect on Male Rats after Administration of Kalanchoe blossfeldiana Crassulaceae Plant Aqueous Crude Extract,” Advanced Contraceptive Delivery Systems, Vol. 13, No. 1, 1997, pp. 13-21.
[22] B. M. L. Miranda, R. L. Huacuja, V. A. L. López and A. Panduro, “Fitoterapia Molecular Como Parte de la Medicina Alternativa Complementaria en las Enfermedades del Hígado,” Investigación en Salud, Vol. 7, 2005, pp. 64-70.
[23] R. Misha and O. Cohen, “Herbal Complementary and Alternative Medicine Therapies for Liver Disease,” Clinical in Liver Disease, Vol. 5, No. 2, 2001, pp. 461-468.
[24] E. Speroni, R. Cervelallati and P. Govoni, “Efficacy of Different Cynara scolymus Preparations on Liver Complains,” Journal of Ethnopharmacology, Vol. 86, No. 2-3, 2003, pp. 203-211. doi:10.1016/S0378-8741(03)00076-X
[25] G. Shcmeda-Hirschmann and Y. Erdem, “Traditional Medicine and Gastroprotective Crude Drugs,” Journal of Ethnopharmacology, Vol. 100, No. 1-2, 2005, pp. 61-66. doi:10.1016/j.jep.2005.06.002
[26] A. M. Panico, V. Carkile and Y. Garuti, “Effect of Hyaluronic Acid and Polysacarides from Opuntia ficus indica (L) Cladodes on the Metabolism of Human Chondrocyte Cultures,” Journal of Ethnopharmacology, Vol. 111, No. 2, 2007, pp. 315-321. doi:10.1016/j.jep.2006.11.020
[27] H.-P. Guan, Y. Li, M. V. Jensen, C. B. Newgard, C. M. Steppan and M. A. Lazar, “A Futile Metabolic Cycle Activated in Adipocytes by Antidiabetic Agents,” Nature Medicine, Vol. 8, No. 10, 2002, pp. 1122-1128. doi:10.1038/nm780
[28] W. L. Li, H. C. Zheng, J. Bukuru and N. De Kimpe, “Natural Medicines Used in the Traditional Chinese Medical System for Therapy of Diabetes Mellitus,” Journal of Ethnopharmacology, Vol. 94, No. 1, 2004, pp. 1-21. doi:10.1016/j.jep.2003.12.031
[29] V. Vats, J. K. Grover and S. S. Rathi, “Evaluation of Anti-Hyperglycemic and Hypoglucemic Effect of Trigonella foenumgraecum Lin, Ocinum sanctum Lin and Pterocarpus marsupium in Normal and Alloxanized Diabetics Rats,” Journal of Ethnopharmacology, Vol. 79, No. 1, 2002, pp. 95-100. doi:10.1016/S0378-8741(01)00374-9
[30] S. M. Downer, M. M. Cody and P. McCluskey, “Pursuit and Practice of Complementary Therapies by Cancer Patients Receiving Conventional Treatment,” British Medical Journal, Vol. 309, 1994, pp. 86-89.
[31] E. Ernst and S. R. Casillech, “The Prevalence of Com- plementary/Alternative Medicine in Cancer: A Systematic Review,” Cancer, Vol. 8, No. 4, 1998, pp. 10-15.
[32] A. Y. Oubre, T. J. Carlson, S. R. King and G. M. Reaven, “From Plant to Patient and Ethnomedical Approach to the Identification of New Drugs for the Treatment of NIDDM,” Diabetologia, Vol. 40, No. 5, 1997, pp. 614-617.
[33] S. E. Inzuchi, “Oral Antihyperglycemic Therapy for Type 2 Diabetes/Scientific Review,” The Journal of the American Medical Association, Vol. 287, No. 3, 2002, pp. 360-372.
[34] N. Morral, “Novel Targets and Therapeutic Strategies for Type 2 Diabetes,” Trends in Endocrinology and Metabolism, Vol. 14, No. 4, 2003, pp. 169-175. doi:10.1016/S1043-2760(03)00031-6
[35] L. D. May, J. H. Leftorowitch M. T. Kram and D. E. Rubin, “Mixed Hepatocelular Cholestatic Liver Injury after Pioglitazone Therapy,” Annals of Internal Medicine, Vol. 136, No. 6, 2002, pp. 449-452.
[36] J. Lieu, “Oleanolic Acid: Research Perspectives,” Journal of Ethnopharmacology, Vol. 100, No. 1-2, 2005, pp. 92-94. doi:10.1016/j.jep.2005.05.024
[37] A. Matzumoto, Y. Matsukawa and T. Suzuki, “The Polymer Allows Method as a New Preparation Method of Biodegradable Microspheres: Principle and Applications to Cisplatin Loaded Microspheres,” Journal of Controlled Release, Vol. 48, No. 1, 1997, pp. 19-27. doi:10.1016/S0168-3659(97)00031-X
[38] M. Yokohama, M. Miyauchi, N. Yamada, T. Okano, Y. Sakurai, K. Kataa and S. Inoue, “Characterization and Anticancer Activity of the Michelle-Formi Polymeric Anticancer Drug Adramycin-Conjugated Poly (Ethylen- glicol)-poly(aspartic acid) Block Copolymer,” Cancer Research, Vol. 15, No. 50, 1990, pp. 1693-1700.
[39] N. Nishiyama, S. Okasaki and H. Cabral, “Novel Cisplatin-Incorporated Polymeric Micelles Can Eradicate Solid Tumors in Mice,” Cancer Research, Vol. 63, No. 24, 2003, pp. 8977-8983.
[40] A. Kumiko, Y. Masako and M. Tatzuya, “Carbon Nanohom as Anticancer Drugs Carriers,” Molecular Pharmacology, Vol. 2, No. 6, 2005, pp. 475-480. doi:10.1021/mp0500566
[41] L. Zhang, M. John and W. Q. Strong, “Scientific Perspectives and Drug Transporters and Their Role in Drug Interactions,” Molecular Pharmacology, Vol. 3, No. 1, 2006, pp. 62-69. doi:10.1021/mp050095h
[42] E. Lugo Estrada, “Observaciones Clínicas de Plantas Medicinales en Diabetes,” 2nd Edition, Universidad Autónoma Chapingo, Chaopingo, 1999.
[43] V. Lassara and M. R. Palace, “Diabetes and Advanced Glycation and Products,” Journal of Internal Medicine, Vol. 251, No. 2, 2002, pp. 87-101.
[44] X. Miaomiao, H. Chunxu and T. Haiteng, “Antioxidant and Antiglycation Properties of Total Saponins Extracted from Traditional Chinese Medicine Used to Treat Diabetes Mellitus,” Phytotherapy Research, Vol. 22, No. 2, 2007, pp. 228-237.
[45] J. I. Sotelo-Felix, D. Martinez-Fong and P. Muriel de la Torre, “Protective Effect of Carnosol on CCl4 Induced Acute Liver Damage Rats,” European Journal of Gas- troenterology & Hepatology, Vol. 14, No. 9, 2002, pp. 1001-1006. doi:10.1097/00042737-200209000-00011
[46] C. Kuklinsky, “Farmacognosia/Estudio de las Drogas y Sustancias Medicamentosas de Origen Natural,” 1st Edition, Omega Ediciones, Barcelona, 2000.
[47] A. Andrade-Cetto and M. Heinrich, “Mexican Plants with Hipoglycaemic Effect Used in the Treatment of Diabetes,” Journal of Ethnopharmacology, Vol. 99, No. 3, 2005, pp. 325-348. doi:10.1016/j.jep.2005.04.019
[48] A. Medina Navarro and J. J. Hicks Gomez, “Radicales Libres de Oxigeno,” In: J. J. Hicks Gomez, Ed., Bioquimica Inorganica y Biomedicina, Interamericana McGraw Hill, Mexico City, 2000, pp. 970-910.
[49] J. Bland, “Biochemical Consequences of Lipid Peroxi- dation,” Journal of Medical Education, Vol. 55, No. 3, 1978, pp. 151-155.
[50] L.-Q. Tang, W. Wei, L.-M. Chen and S. Liu, “Effects of Berberine on Diabetes Induced by Alloxan and a High-Fat/High-Cholesterol Diet in Rats,” Journal of Ethnopharmacology, Vol. 108, No. 1, 2006, pp. 109-115. doi:10.1016/j.jep.2006.04.019
[51] A. Chamorro, V. Obach, A. Cervera, M. Revilla, R. Deulofeu and J. H. Aponte, “Pronositic Significance of Uronic Acid Serum Concentration in Patients with Acute Ischemic Stroke,” Stroke, Vol. 33, No. 4, 2002, pp. 1048-1052.

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.